Indeed at 3–4 weeks treatment with the LSD1 inhibitor, we observed a significant reduction in average tumour volume versus vehicle treated mice; importantly, we did not observe toxicity-associated changes in body or organ weight (Supplementary Figure S1). This evidence concerns the gene KDM1A and neoplasm.